The role of proprotein convertase subtilisin kexin 9 (PCSK9) in preeclampsia with severe features

被引：1
|
作者：
Bishop, Juliet [1 ]
Shaddeau, Angela [2 ]
Darwin, Kristin C. [1 ]
Wilson, Tenisha [1 ]
Boyer, Theresa [1 ]
Debrosse, Alexia [3 ]
Sharma, Garima [1 ]
Vaidya, Dhananjay [1 ]
Ouyang, Pamela [1 ]
Mukherjee, Monica [1 ]
Zakaria, Sammy [1 ]
Leucker, Thorsten [1 ]
Vaught, Arthur J. [1 ]
机构：
[1] Johns Hopkins Sch Med, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Germantown, MD USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2020年 / 222卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2019.11.888
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
875
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [31] Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis
    Cammisotto, Vittoria
    Baratta, Francesco
    Simeone, Paola G.
    Barale, Cristina
    Lupia, Enrico
    Galardo, Gioacchino
    Santilli, Francesca
    Russo, Isabella
    Pignatelli, Pasquale
    ANTIOXIDANTS, 2022, 11 (03)
  • [32] Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) on Lipid Metabolism and Insulin Resistance in Human
    Muraki, Isao
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (04) : 317 - 318
  • [33] The role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in the pathophysiology of psoriasis and systemic lupus erythematosus
    Fratczak, Aleksandra
    Polak, Karina
    Szczepanek, Michal
    Lis-Swiety, Anna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (04): : 645 - 650
  • [34] Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19
    Mester, Patricia
    Amend, Pablo
    Schmid, Stephan
    Mueller, Martina
    Buechler, Christa
    Pavel, Vlad
    VIRUSES-BASEL, 2023, 15 (07):
  • [35] Longitudinal measurements of proprotein convertase subtilisin kexin 9 (PCSK-9) in patients with and without preeclampsia
    Shaddeau, Angela
    Bishop, Juliet
    Wilson, Tenisha
    Darwin, Kristin C.
    Boyer, Theresa
    Debrosse, Alexia
    Sharma, Garima
    Vaidya, Dhananjay
    Ouyang, Pamela
    Mukherjee, Monica
    Zakaria, Sammy
    Leucker, Thorsten
    Vaught, Arthur J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S295 - S295
  • [36] Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary Prevention
    Zhu, Yiming M.
    Anderson, Todd J.
    Sikdar, Khokan
    Fung, Marinda
    McQueen, Matthew J.
    Lonn, Eva M.
    Verma, Subodh
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (10) : 2254 - 2259
  • [37] Plasma Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in the Acute Respiratory Distress Syndrome
    Metkus, Thomas S.
    Kim, Bo Soo
    Jones, Steven R.
    Martin, Seth S.
    Schulman, Steven P.
    Leucker, Thorsten M.
    FRONTIERS IN MEDICINE, 2022, 9
  • [38] Mutations and Polymorphisms in the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Gene in Cholesterol Metabolism and Disease
    Abifadel, Marianne
    Rabes, Jean-Pierre
    Devillers, Martine
    Munnich, Arnold
    Erlich, Daniele
    Junien, Claudine
    Varret, Mathilde
    Boileau, Catherine
    HUMAN MUTATION, 2009, 30 (04) : 520 - 529
  • [39] PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) LEVEL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN RUSSIA
    Benimetskaya, Kseniya
    Ragino, Yulia
    Shakhtshneider, Elena
    Makarenkova, Kseniya
    Stakhneva, Ekaterina
    Astrakov, Sergey
    Shchepina, Yulia
    Voevoda, Mikhail
    ATHEROSCLEROSIS, 2017, 263 : E195 - E195
  • [40] Antitumor activity and molecular mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition
    Sun, Huimin
    Meng, Wen
    Zhu, Jie
    Wang, Lu
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (06) : 643 - 658
12345